A Literature-Based Review and Analysis of the Pharmacodynamics of the Dose Frequency of Topical 0.3% Ciprofloxacin and 0.3% Ofloxacin in the Day-1 Treatment of Bacterial Keratitis
- 1 February 2023
- journal article
- review article
- Published by Mary Ann Liebert Inc in Journal of Ocular Pharmacology and Therapeutics
- Vol. 39 (1), 17-26
- https://doi.org/10.1089/jop.2022.0110
Abstract
Purpose: To determine the appropriate dose frequency for the second-generation fluoroquinolones (2FQs), ciprofloxacin 0.3% and ofloxacin 0.3%, in the day-1 treatment of bacterial keratitis (BK) based on the corneal concentrations achievable and required Minimum Inhibitory Concentration90 (MIC90) of common BK isolates. Methods: Literature-based ocular MIC90 required to treat bacterial isolates of BK patients were determined for each fluoroquinolone. Published corneal concentrations for each 2FQ, and the drop regimens used to reach these concentrations, were then analyzed to determine the relationship between the corneal 2FQ concentration and the amount of drug applied per hour and the total amount applied. Results: Significant relationships were found to exist for corneal concentrations of both ciprofloxacin and ofloxacin and the amount of drug applied per hour (both P = 0.005), and the total amount of drug applied (P = 0.003 and P = 0.0004, respectively). Derived ciprofloxacin drops/hour corneal concentrations agreed well with both a literature-based regimen and the manufacturers' day-1 drop regimen for various MIC90. Derived ofloxacin drops per hour indicated a higher rate than that suggested by the manufacturer. Conclusions: Both a literature-based and the manufacturers' drop regimens for the day-1 treatment of BK using 0.3% ciprofloxacin have a pharmacodynamic basis, which is related to the required MIC90 of commonly encountered isolates in BK. Dose frequency for 0.3% ofloxacin should be in line with the manufacturers' maximum suggested drop regimen. Commonly suggested drop regimens below these recommendations for either FQ may need to be revised in view of these findings.Keywords
This publication has 48 references indexed in Scilit:
- Regulation and Function of Versatile Aerobic and Anaerobic Respiratory Metabolism in Pseudomonas aeruginosaFrontiers in Microbiology, 2011
- The patterns of in vitro antimicrobial susceptibility and resistance of bacterial keratitis isolates in Glasgow, United KingdomClinical and Experimental Optometry, 2010
- Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-testIndian Journal of Pathology and Microbiology, 2010
- FluoroquinolonesDrugs, 2001
- OfloxacinDrugs, 1991
- Transintestinal elimination of ciprofloxacinDiagnostic Microbiology and Infectious Disease, 1990
- Clinical Pharmacokinetics of the Newer Antibacterial 4-QuinolonesClinical Pharmacokinetics, 1988
- THE CONCURRENT APPLICATION OF OPHTHALMIC DROPSAustralian and New Zealand Journal of Ophthalmology, 1985
- Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteersEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Pharmacokinetics of Instilled Drugs in the Human EyeInternational Ophthalmology Clinics, 1980